Antigiardiais Effects of New Metronidazole Derivatives on Trophozoites in TYI-S-33 Antigiardiais effects of metronidazole derivatives
Iranian Journal of Pharmaceutical Sciences,
Vol. 7 No. 3 (2011),
1 July 2011
,
Page 181-184
https://doi.org/10.22037/ijps.v7.41319
Abstract
Giardia is a flagellate protozoan with worldwide distribution that causes significant gastrointestinal diseases. The life cycle of the organism alternates between the active, proliferating trophozoite and the dormant cyst. 5-Nitroimidazoles have been used extensively in the treatment of amoebiasis, giardiasis, and trichomoniasis. We have previously synthesized some new analogues of metronidazole containing a phenyl or cyclohexanol ring in the side chain of the imidazole ring, and evaluated their antigiardiasis activity on giardia cyst. In the present study, we evaluated their activity against trophozoites of the parasite. For this purpose TYI-S-33 media was used and their MIC were compared with metronidazole and DMSO as positive and negative controls, respectively. The results showed that the new compounds had desirable antigiardiasis activities. Analogues which contain phenyl group in their structure are more active than those which contain cyclohexanol moiety. Although all the new compounds had higher MIC than metronidazole but their antigiardiasis activity were comparable to metronidazole and they may prove good alternatives for metronidazole. Keywords: Giardiasis; Metronidazole; Trophozoite.
- Giardiasis
- Metronidazole
- Trophozoite.
How to Cite
References
[2] Scorza AV, Lappin MR. Metronidazole for the treatment of feline giardiasis. J Feline Med Surg 2004; 6: 157-60.
[3] Turner ML, Cockerell EJ, Brereton HM, Badenoch PR, Tea M, Coster DJ, Williams KA. Antigens of selected Acanthamoeba species detected with monoclonal antibodies. Int J Parasitol 2005; 35: 981-90.
[4] Karabay O, Tamer A, Gunduz H, Kayas D, Arinc H, Celebi H. Albendazole versus metronidazole treatment of adult giardiasis: an open randomized clinical study. World J Gastroentrol 2004; 10:1215-7.
[5] Adam RD. The biology of Giardia spp. Microbiol Rev 1991; 55: 706-32.
[6] Cavas T, Ergene-Gozukara S. Genotoxicity evaluation of metronidazole using the piscine micronucleus test by acridine orange fluorescent staining. Environ Toxicol Pharmacol 2005; 19:107-11.
[7] Bharti N, Athar F, Maurya MR, Azam A.Synthesis, characterization and in vitro antiamoebic activity of new palladium (II) complexes with 5-nitrothiophene-2-carboxaldehyde N (4)-substituted thiosemicarbazones. Bioorg Med Chem 2004; 12: 4679-84.
[8] Kim DW, Park JM, Yoon BW, Baek MJ, Kim JE, Kim SY. Metronidazole-induced encephalopathy. J Neurol Sci 2004; 224: 107-11.
[9] Gómez-Arroyo S, Melchor-Castro S, Villalobos-Pietrini R, Camargo EM, Salgado-Zamora H, Campos Aldrete M. Cytogenetic study of metronidazole and three metronidazole analogues in cultured human lymphocytes with and without metabolic activation. Toxicol in vitro 2004; 18:319-24.
[10] Upcroft JA, Campbell RW, Benakli K, Upcroft P, Vanelle P. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and-resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother 1999; 43: 73-6.
[11] Khabnadideh S, Rezaei Z, Khalafi Nezhad A, Motazedian MH, Eskandari M. Synthesis of metronidazole derivatives as antigiardiasis agents. Daru 2007; 17: 20.
[12] Bonilla-Santiago R, Wu Z, Zhang L, Widmer G. Identification of growth inhibiting compounds in a Giardia lamblia high-throughput screen. Molecular Biochem Parasitol 2008; 162: 149-54.
[13] Luján HD, Mowatt MR, Nash TE. The molecular mechanisms of giardia encystation. Parasitol Today 1998; 14: 446-50.
[14] Elmendorf HG, Dawson SC, McCaffery JM. The cytoskeleton of giardia lamblia. Internat J Parasitol 2003; 33: 3-28.
- Abstract Viewed: 234 times
- IJPS_Volume 7_Issue 3_Pages 181-184 Downloaded: 205 times